Catalyst Funds Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-576
Closed -$9.92K 587
2025
Q4
$9.92K Buy
+576
New +$11.2K ﹤0.01% 330
2025
Q3
Sell
-424
Closed -$24.4K 487
2025
Q2
$24.4K Buy
+424
New +$34K 0.01% 419

Other funds holding AGL

Catalyst Funds Management's AGL Position: Q1 2026 in Review

Catalyst Funds Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 576 shares — an estimated $9.92K sold.

Catalyst Funds Management first reported a position in AGL in Q2 2025 and held it in 2 quarters. The position peaked at $24.4K in Q2 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Catalyst Funds Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 576 Agilon Health shares in Q1 2026, an estimated $9.92K.
  • Catalyst Funds Management first reported a position in Agilon Health in Q2 2025 and held it in 2 quarters.
  • Catalyst Funds Management's Agilon Health position peaked at $24.4K in Q2 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.